Low Levels of Low-Density Lipoprotein Cholesterol and Blood Pressure and Progression of Coronary AtherosclerosisCHHATRIWALLA, Adnan K; NICHOLLS, Stephen J; WANG, Thomas H et al.Journal of the American College of Cardiology. 2009, Vol 53, Num 13, pp 1110-1115, issn 0735-1097, 6 p.Article

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the DCHARISMA trial. CommentarySEREBRUANY, Victor L; WANG, Thomas H; STEG, P. Gabriel et al.European heart journal. 2007, Vol 28, Num 18, issn 0195-668X, 2183-2184, 2200-2207 [10 p.]Article

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisBECKER, Matthew C; WANG, Thomas H; GRAHAM, David Y et al.The American heart journal. 2009, Vol 157, Num 4, pp 606-612, issn 0002-8703, 7 p.Article

Aspirin and clopidogrel resistance : an emerging clinical entityWANG, Thomas H; BHATT, Deepak L; TOPOL, Eric J et al.European heart journal. 2006, Vol 27, Num 6, pp 647-654, issn 0195-668X, 8 p.Article

Extensive fibromuscular dysplasia in a patient with Parkinson diseaseWANG, Thomas H; MAURO, Matthew; JENNETTE, J. Charles et al.The American journal of the medical sciences. 2004, Vol 327, Num 6, pp 352-355, issn 0002-9629, 4 p.Article